Doctors Without Borders calls on J&J to withdraw extended patents on TB drug

AS Johnson & Johnson's (J&J) 20-year primary patent on the critical, lifesaving drug-resistant tuberculosis (DR-TB) drug bedaquiline expires in majority of countries, including India, Doctors Without Borders/Médecins Sans Frontières (MSF) reiterated its call for the US pharmaceutical corporation to publicly announce it will not enforce any 'secondary' patents for the drug in any country with a high burden of TB and withdraw and abandon all pending secondary patent applications for this critical drug everywhere.

Related Keywords

Barangay ,Pangasinan ,Philippines ,Manila ,New York ,United States ,India ,Johnson ,Trisha Thadhani ,World Health Organization ,Terms Of Service ,Doctors Without Borders ,Doctors Without ,Sans Fronti ,Tondo Districts ,Without Borders ,Manila Times ,Doctors ,Without ,Borders ,Calls ,Son ,J ,To ,Withdraw ,Extended ,Patents ,Tb ,Drug ,